Clinical Trial Search

Primary: Body Weight — -2.3; 0.73 kg — p=<0.01

Primary: Recurrent Infection — 1; 3; 1 participants

Primary: Change in the Alcohol Use Disorders Identification Test (AUDIT) Score Over Time — -5.8; -4.0 score on a scale

Primary: Sexual Risk Behavior — 1; 2 Participants

Primary: Evidence-based Decision Making (EBDM) Competencies — 2.05; 1.98 score on a scale

Primary: Composite Cancer Screening Tests up to Date — 3087; 2590; 3866 Participants — p=.025

Primary: Number of Participants With Symptomatic COVID-19 at 60 Days — 24; 19 Participants — p=0.52

Primary: Number of Incident Diabetes-related ED Visits and/or Hospitalizations — .88; 1.29 Incidence rate ratio — p=.12

Primary: Enrollment and Recruitment Rate — 61; 62 Participants

Primary: Total Number of MDRO (Multidrug Resistant Organisms) Isolated — 1299; 1732 Total Number of MDRO isolates — p=<0.05

Primary: Body Mass Index (BMI) - Post-Test — 30.3; 28.8 kg/m2

Primary: Aim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal Cancers — 85; 85; 85; 85 Participants

Primary: Emergency Department and In-patient Hospitalization for Fall Injury — 5.8; 5.9; 6.1; 5.8 Fall Injury Rate per 100 person years — p=<0.05

Primary: Overdose Risk Behavior — -1.54; -0.51 Scores on a scale

Primary: Change in the Addiction Treatment Accessibility and Utilization as Assessed by Change in Likert Scale — 1.26; 1.07; 1.12; 1.03 score on a scale — p=0.84

Primary: Number of Participants With Eradication of H. Pylori (ITT) — 49; 54 Participants

Primary: Proportion of Condom Usage — .68; .56 proportion of condom use

Primary: Illicit Drug Use Days — 1.49; .80; 1.16; 0.83 days — p=.433

Primary: Number of PCP Visits Where Ppt Was Referred to Diabetes Prevention Program Within 30 Days of Visit — 47; 10 pcp visits

Primary: Risk of Fatal Coronary Event or Non-fatal MI — 27.0; 26.3 percent risk of major cv event in 10 yrs — p=0.50

Primary: Systolic Blood Pressure — 134.9; 134.9; 129.9; 136.3 model estimated mmhg

Primary: Change in Body Mass Index Z-score — -0.01; 0.00; -0.04 Z-Score

Primary: Changes in Weight Between Baseline and Post-intervention (Assessed at 6 Months After Commencement of Intervention) Compared to Delayed Intervention Participants…

Primary: Number of Control and Intervention Participants on Skin Self-examination Performance at Follow-up 1 Month After Intervention — 34; 8 Participants

Primary: Number of Infected Subjects — 0; 11 Participants — p=< 0.0001

Primary: Initiation of Sexual Intercourse — 308; 509 participants

Primary: Number of Participants With Visit to a Cardiology Specialist From Cohort — 283 Participants

Primary: Feasibility as Measured by the Number of Total Scheduled Intervention Sessions (CHW Counseling Sessions, Doctor's Visits, Phone Calls) Attended — 589 Scheduled sessions

Primary: Percentage of Participants to Learn New Information — 38.6 percentage of participants

Primary: Number of Unprotected Acts of Intercourse — 19.7; 12.9; 18.2 # of unprotected sex acts at 12 months